Hutchmed weighs cancer drug’s supply-chain options amid US-China trade war
Blood-cancer medicine, manufactured in the US, won conditional approval for sale in mainland China last month.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
